Clik here to view.
The Realm Of Next Generation Sequencing
Breaking Down The Genome A billion dollar budget, a decade of work, and multinational collaboration brought the first human genome sequence—via the Human Genome Project—to the world at the turn of the...
View ArticleIs Genetic Variety The Spice Of Life?
Understanding Basis Of Evolution Take a look at the person closest to you. Compare the color of their eyes, the texture of their hair, even the complexion of their skin to your own. Do you notice a lot...
View ArticleDrugging The Undruggable
Antagonists Fight A Good Fight Small molecule inhibitors, also known as antagonists in the industry, fight a good fight. In fact, many drugs on the market today work by inhibiting overactive,...
View ArticleClik here to view.
Post-translational Modifications In Biotech
Basic Science Meets Application “Post-translational modification” may not be a term you hear every day, but it is critically important to the biotech industry—from understanding how cancer develops to...
View ArticleClik here to view.
Putting The NA in DNA
Nucleic Acid Therapeutics Small molecule, peptide, and biologic drugs aren’t the only players in the game of drug development. A fourth class of therapeutics differs from all three of these: nucleic...
View ArticlePost-translational Modifications In Biotech
Basic Science Meets Application “Post-translational modification” may not be a term you hear every day, but it is critically important to the biotech industry—from understanding how cancer develops to...
View ArticleThe ABCs of DNA & RNA
Nucleic Acid Therapeutics Small molecule, peptide, and biologic drugs aren’t the only players in the game of drug development. A fourth class of therapeutics differs from all three of these: nucleic...
View ArticleBlueprint Of The Century: DNA
Emily Burke, PhDAuthor Emily Burke, PhD has worked in biopharma for 20 years, gaining science writing experience at The Scripps Research Institute and Ionis Pharmaceuticals. As a Ph.D. molecular...
View Article
